A multicenter, double-blind, placebo-controlled, parallel-group, comparison study of the efficacy and safety of ipsapirone versus lorazepam in outpatients with generalized anxiety disorder (GAD)

Generalized Anxiety ◽

Group Comparison ◽

Comparison Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group

Long-term efficacy and safety of agomelatine in non-depressed out-patients with generalized anxiety disorder. A 26-week randomised double-blind placebo-controlled parallel group study following an open-label period of 16 weeks with agomelatine (25 mg/day with the possibility for blinded dose-adjustment to 50 mg/day)

http://isrctn.org/> ◽

10.1186/isrctn38094599 ◽

2012 ◽

Author(s):

Istvan Bitter

Keyword(s):

Anxiety Disorder ◽

Dose Adjustment ◽

Generalized Anxiety ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group

Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study

Sleep Medicine ◽

10.1016/j.sleep.2021.01.018 ◽

2021 ◽

Vol 80 ◽

pp. 315-321

Author(s):

Yuichi Inoue ◽

Toshiyuki Tabata ◽

Naoji Tsukimori

Keyword(s):

Sleep Time ◽

Group Comparison ◽

Comparison Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group ◽

Long Sleep ◽

Idiopathic Hypersomnia

Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: a randomized, double‐blind, placebo‐controlled trial

International Journal of Geriatric Psychiatry ◽

10.1002/gps.4088 ◽

2014 ◽

Vol 29 (9) ◽

pp. 978-986 ◽

Cited By ~ 20

Author(s):

Karla J. Alaka ◽

William Noble ◽

Angel Montejo ◽

Héctor Dueñas ◽

Autar Munshi ◽

...

Keyword(s):

Anxiety Disorder ◽

Older Adult ◽

Controlled Trial ◽

Adult Patients ◽

Generalized Anxiety ◽

Efficacy And Safety ◽

Double Blind ◽

Efficacy and safety of agomelatine (10 or 25 mg/day) in non-depressed out-patients with generalized anxiety disorder: A 12-week, double-blind, placebo-controlled study

European Neuropsychopharmacology ◽

10.1016/j.euroneuro.2017.02.007 ◽

2017 ◽

Vol 27 (5) ◽

pp. 526-537 ◽

Cited By ~ 16

Author(s):

Dan J. Stein ◽

Antti Ahokas ◽

Marek Jarema ◽

Alla S. Avedisova ◽

Livia Vavrusova ◽

...

Keyword(s):

Anxiety Disorder ◽

Controlled Study ◽

Generalized Anxiety ◽

Efficacy And Safety ◽

Double Blind ◽

A Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Ipsapirone Versus Lorazepam in Patients With Generalized Anxiety Disorder

Journal of Clinical Psychopharmacology ◽

10.1097/00004714-199312000-00009 ◽

1993 ◽

Vol 13 (6) ◽

pp. 429???437 ◽

Cited By ~ 40

Author(s):

NEAL R. CUTLER ◽

JOHN J. SRAMEK ◽

JAN M. KEPPEL HESSELINK ◽

ALICE KROL ◽

JULIE ROESCHEN ◽

...

Keyword(s):

Anxiety Disorder ◽

Controlled Study ◽

Generalized Anxiety ◽

Efficacy And Safety ◽

Double Blind ◽

Treatment of generalized anxiety disorder with escitalopram: Pooled results from double-blind, placebo-controlled trials

Journal of Affective Disorders ◽

10.1016/j.jad.2004.11.011 ◽

2005 ◽

Vol 87 (2-3) ◽

pp. 161-167 ◽

Cited By ~ 65

Author(s):

Wayne K. Goodman ◽

Anjana Bose ◽

Qin Wang

Keyword(s):

Anxiety Disorder ◽

Generalized Anxiety ◽

Controlled Trials ◽

Double Blind ◽

P.4.025 Tiagabine in generalized anxiety disorder: a randomized, double-blind, placebo-controlled study

European Neuropsychopharmacology ◽

10.1016/s0924-977x(05)81124-1 ◽

2005 ◽

Vol 15 ◽

pp. S538

Keyword(s):

Anxiety Disorder ◽

Controlled Study ◽

Generalized Anxiety ◽

Double Blind ◽

Double-blind, placebo-controlled study of once daily venlafaxine XR in outpatients with generalized anxiety disorder

European Neuropsychopharmacology ◽

10.1016/s0924-977x(98)90082-7 ◽

1998 ◽

Vol 8 ◽

pp. S26

Keyword(s):

Anxiety Disorder ◽

Controlled Study ◽

Generalized Anxiety ◽

Double Blind ◽

Once Daily ◽

Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison study

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/j.1468-3083.2012.04716.x ◽

2012 ◽

Vol 27 (3) ◽

pp. e376-e383 ◽

Cited By ~ 67

Author(s):

K.A. Papp ◽

R. Kaufmann ◽

D. Thaçi ◽

C. Hu ◽

D. Sutherland ◽

...

Keyword(s):

Phase Ii ◽

Plaque Psoriasis ◽

Comparison Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Severe Plaque Psoriasis ◽

Dose Comparison ◽

Parallel Group

Duloxetine in treating generalized anxiety disorder in adults: A meta-analysis of published randomized, double-blind, placebo-controlled trials

Asia-Pacific Psychiatry ◽

10.1111/appy.12203 ◽

2015 ◽

Vol 8 (3) ◽

pp. 215-225 ◽

Cited By ~ 4

Author(s):

Yingli Zhang ◽

Guoping Huang ◽

Shichang Yang ◽

Wei Liang ◽

Lei Zhang ◽

...

Keyword(s):

Anxiety Disorder ◽

Meta Analysis ◽

Generalized Anxiety ◽

Controlled Trials ◽

Double Blind ◽